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Background: Centralizing specialist cancer surgery services aims to reduce variations in quality of care
and improve patient outcomes, but increases travel demands on patients and families. This study aimed
to evaluate preferences of patients, health professionals and members of the public for the characteristics
associated with centralization.
Methods: A discrete-choice experiment was conducted, using paper and electronic surveys. Participants
comprised: former and current patients (at any stage of treatment) with prostate, bladder, kidney or
oesophagogastric cancer who previously participated in the National Cancer Patient Experience Survey;
health professionals with experience of cancer care (11 types including surgeons, nurses and oncologists);
and members of the public. Choice scenarios were based on the following attributes: travel time to
hospital, risk of serious complications, risk of death, annual number of operations at the centre, access to
a specialist multidisciplinary team (MDT) and specialist surgeon cover after surgery.
Results: Responses were obtained from 444 individuals (206 patients, 111 health professionals and 127
members of the public). The response rate was 52⋅8 per cent for the patient sample; it was unknown
for the other groups as the survey was distributed via multiple overlapping methods. Preferences were
particularly influenced by risk of complications, risk of death and access to a specialist MDT. Participants
were willing to travel, on average, 75 min longer in order to reduce their risk of complications by 1 per
cent, and over 5 h longer to reduce risk of death by 1 per cent. Findings were similar across groups.
Conclusion: Respondents’ preferences in this selected sample were consistent with centralization.
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Introduction
Centralization of cancer surgical services is occurring in
some parts of Europe, the USA and Canada1–3. In the UK,
the importance of seeking new models of care, including
centralization where appropriate, has been emphasized in
Five Year Forward View4. There have been initiatives of this
type in oesophagogastric cancer services5–7. The National
Cancer Strategy is currently evaluating whether cancer
surgery merits further centralization8. In London since
2011, and Greater Manchester since 2014, cancer care
has been provided in ‘integrated cancer systems’, working
towards centralization of specialist surgical pathways for
prostate, bladder, kidney and oesophagogastric cancers.
The rationale for centralizing specialist cancer surgery
services is to reduce unacceptable variation in quality of
care and outcomes achieved by different centres9. Higher
volume might be associated with better outcomes for
oesophagogastric10, rectal11 and urological12,13 cancers.
Centralizing other services can lead to better outcomes
too14–19.
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There are several reasons why centralization may
improve outcomes. Increased patient volume permits
greater specialization, experience and expertise of staff20.
Greater numbers of patients may allow equal access to
innovative technologies9,20. On the other hand, many
aspects of care are still likely to be provided by local
hospitals, including diagnosis and ongoing chemotherapy,
with only complex surgery or other interventions (such
as brachytherapy) likely to be provided at the specialist
centre21. After centralization, local hospitals may have
closer involvement with specialist centre staff, for example
via joint multidisciplinary team (MDT) meetings, with
the potential to improve quality of care across the whole
system9,22. One disadvantage of centralization is that
it leads to increased travel demands, limiting access to
high-quality care23 and to support from family and friends.
The aim of this study was to examine preferences of
patients, health professionals and the general public for
the characteristics associated with centralizing specialist
cancer surgery services in England, including the relative
importance of different service characteristics and how
preferences varied between groups.
Methods
Preferences were explored using a discrete-choice experi-
ment (DCE)24. In DCEs, respondents are typically pre-
sented with a series of questions, asking them to choose
between two or more alternatives that describe a service
in terms of a set of characteristics (attributes). This allows
the attributes of a service that respondents prefer to be
evaluated, as well as the trade-off they are willing to make
between attributes. These methods have been used to com-
pare preferences between patients and doctors for the sur-
gical management of oesophagogastric cancer25.
Ethical approval for this study was granted by the
Proportionate Review Sub-committee of the National
Research Ethics Service Committee Yorkshire and the
Humber – Leeds. DCE guidelines were followed for
study design and analysis24,26.
Sampling and recruitment
DCE responses were obtained from three groups: patients
with prostate, bladder, kidney and oesophagogastric can-
cer (target sample size 200); health professionals involved
in the care of patients with these types of cancer (100);
and members of the public (individuals who have not
experienced these 4 types of cancer and are not health
professionals caring for patients with these types of
cancer; 100). Data were collected by hard-copy postal
questionnaires that were sent to patients, and online
surveys (patients, public, health professionals).
The patient sample comprised people who had previ-
ously participated in the National Cancer Patient Experi-
ence Survey (www.ncpes.co.uk) and agreed to be involved
in future research. The authors invited former and current
patients with prostate, bladder, kidney and oesophagogas-
tric cancers, some of whom may also have been diagnosed
with other cancers. The aim was to recruit 50 patients from
London, 50 from Greater Manchester and 100 from the
rest of England. Health professionals with experience of
caring for patients with these four types of cancer were
recruited via the mailing lists of the British Association
of Urological Surgeons, the Association of Upper Gas-
trointestinal Surgeons, the UK Oncology Nursing Soci-
ety, the Bladder and Renal Cancer Clinical Studies Group,
the Prostate Cancer Clinical Studies Group, the Psychoso-
cial Oncology and Survivorship Clinical Studies Group,
and the Contact, Help, Advise and Information Net-
work; the RESPECT-21 (Reorganising specialist cancer
surgery for the 21st century: a mixed methods evaluation)
newsletter; and the National Institute for Health Research
(NIHR) Collaboration for Leadership in Applied Health
Research and Care (CLAHRC) North Thames and NIHR
CLAHRC Greater Manchester newsletters. The public
sample was recruited through a number of routes: the
Patient Voices charity, 21 HealthWatch local groups (who
represent the views of people who use health and social
care services), the Patients’ Association, the RESPECT-21
newsletter andTwitter account, and theCancer52 charities.
Potential patient participants were sent a hard copy of
the questionnaire by post, including information about the
study that also explained what their participation would
entail. They were invited to complete and return the
enclosed questionnaire, and were told that by doing so they
consented to take part in the study. They were told that
they did not have to take part if they did not want to. For the
public and health professionals, potential respondents were
sent an e-mail inviting them to participate, containing a
weblink to the online survey.When clicking on the weblink
they were provided with study information, as above. They
were asked to click to another webpage to access the sur-
vey, and were informed that by doing so they consented to
take part in the study. They were also told that they did not
have to take part if they did not want to.
Attributes and attribute levels
The attributes and levels used in the DCE describing
the most relevant service characteristics and outcomes
associated with centralization of specialist cancer surgery
were identified in a two-stage process. First, a review of
documents covering development, planning and imple-
mentation of the changes9,21,22,27 was undertaken to
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Table 1 Attributes and levels used in the discrete-choice experiment
Attribute Level
Travel time to hospital for surgery (min) < 30 30–60 60–90 90–120
Risk of serious complications from surgery (%) 1 5 10
Risk of death within 30 days of surgery (%) 0⋅5 1⋅5 2⋅5
No. of operations carried out each year by centre for each type of cancer 10 50 100
Access to MDT to decide treatment Local MDT Specialist MDT
Availability of specialist surgeon cover after operation During normal working hours Specialist surgeon 24/7
MDT, multidisciplinary team; 24/7, 24 h a day, 7 days a week.
Factors Centre A Centre B
Travel time to the hospital to have surgery
(door to door, one way) Up to 30 minutes
5% chance of serious
complications
10 operations per centre
per year
Local MDT
Specialist surgeon
during normal working
hours and general
surgeon for the rest of
the time
Specialist surgeon 24
hours a day, 7
days a week
Specialist MDT
1·5% chance of dying
50 operations per
centre per year
1% chance of serious
complications
Between 60 and 90
minutes
2·5% chance of dying
Risk of serious complications from surgery
Number of operations the centre carries out
each year for each type of cancer
Risk of death within 30 days of surgery
Access to a specialist multidisciplinary team
to decide treatment
Availability of specialist surgeon cover after
the operation
Centre A Centre B
Which centre would you choose for surgery? (Tick one box only.)
Fig. 1 Example of discrete-choice experiment choice set. MDT, multidisciplinary team
determine characteristics of the care pathway and outcomes
that could vary as a result of the proposed changes. A list of
items was derived (Appendix S1, supporting information),
and then a questionnaire was developed to determine the
factors that were important to patients, carers and health
professionals. Respondents were asked to state whether
each item was important from their point of view, with
‘yes’ or ‘no’ as possible answers, and to rank the items
by order of importance. They were also asked to add any
items important to them that were not included in the list.
A convenience sampling approach was used; 52 responses
were received from 19 members of Patient and Public
Involvement (PPI) groups comprising patients with cancer
and carers, and 33 responses from health professionals.
Analysis of the information from the planning docu-
ments and responses from the questionnaires identified six
attributes most likely to be important to respondents and
likely to change as a result of centralizing specialist cancer
surgery services: travel time to hospital, risk of serious
complications from surgery, risk of death within 30 days
of surgery, number of operations the centre carries out
each year, access to a MDT and availability of specialist
surgeon cover after the operation (Table 1). The levels of
each attribute were based on planning documents covering
development, planning and implementation of the changes
(as above) and input from the RESPECT-21 Research
Strategy Group, which included relevant clinical experts
and patient representatives. Descriptions were developed
for each of the attributes to help participants understand
the nature of each attribute that they were being asked
to consider (see complete questionnaire in Appendix S2,
supporting information).
Questionnaire design
In the DCE, respondents were asked to choose their pre-
ferred option from a series of pairwise choices, that is
in which of two fictitious centres would they prefer to
have surgery, or, in the case of health professionals, they
would prefer their patients to have surgery. Each centre
was described by a unique combination of different lev-
els of the attributes; Fig. 1 shows an example of a DCE
question. An opt-out or ‘neither’ option was not included
as people at this stage of the cancer pathway are unlikely
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Table 2 Demographic characteristics by group
Patients (n = 199) Health professionals (n = 109) General public (n = 125)
Age (years)* 69(9) 48(8) 46(16)
Sex ratio (F : M) 41 : 158 45 : 64 85 : 40
Ethnicity – white 186 (93⋅5) 87 (79⋅8) 107 (85⋅6)
Cancer diagnosis
Prostate 67 (33⋅7) 1 (0⋅9) 2 (1⋅6)
Bladder 61 (30⋅7) 0 (0) 0 (0)
Kidney 46 (23⋅1) 0 (0) 2 (1⋅6)
Oesophagus and stomach 38 (19⋅1) 2 (1⋅8) 0 (0)
Other type 17 (8⋅5) 5 (4⋅6) 19 (15⋅2)
Time of diagnosis
This year 0 (0) 1 (0⋅9) 5 (4⋅0)
Last year 107 (53⋅8) 2 (1⋅8) 6 (4⋅8)
≥ 2 years ago 79 (39⋅7) 4 (3⋅7) 16 (12⋅8)
Current stage of treatment
Waiting for decision 4 (2⋅0) 0 (0) 0 (0)
Scheduled for surgery 0 (0) 0 (0) 1 (0⋅8)
Scheduled for other treatment 4 (2⋅0) 0 (0) 0 (0)
Already had surgery 115 (57⋅8) 5 (4⋅6) 17 (13⋅6)
Already had other treatment 64 (32⋅2) 4 (3⋅7) 9 (7⋅2)
Family/friend with cancer diagnosis 97 (48⋅7) 45 (41⋅3) 66 (52⋅8)
Educational qualifications
No formal qualifications 43 (21⋅6) 1 (0⋅8)
Lower than degree 87 (43⋅7) 20 (16⋅0)
Degree or higher degree 44 (22⋅1) 100 (80⋅0)
Employment status
Full-time employed 26 (13⋅1) 59 (47⋅2)
Retired 135 (67⋅8) 30 (24⋅0)
Other 32 (16⋅1) 33 (26⋅4)
Health professional specialty
Surgeon 61 (56⋅0)
Oncologist 6 (5⋅5)
Radiologist 1 (0⋅9)
Physiotherapist 1 (0⋅9)
Pathologist 1 (0⋅9)
Occupational therapist 1 (0⋅9)
Speech and language therapist 3 (2⋅8)
Psychologist 1 (0⋅9)
Dietician 5 (4⋅6)
Nurse 22 (20⋅2)
Other 6 (5⋅5)
Place of residence
London 39 (19⋅6) 27 (24⋅8) 63 (50⋅4)
Manchester 50 (25⋅1) 14 (12⋅8) 8 (6⋅4)
Other location 103 (51⋅8) 65 (59⋅6) 52 (41⋅6)
Values in parentheses are percentages unless indicated otherwise; *values are mean(s.d.). Data were incomplete for some variables.
to choose not to have surgery from one of the available
options.
The number of potential combinations of attributes with
two two-level attributes, three three-level attributes and
one four-level attribute is 432 (22 × 33 × 41). With two
options to choose from in each choice question, this gives
a possible 186 192 choices (432 × 431). To reduce the
number of choices to a manageable number, a fractional
design was applied using the –dcreate– command in
Stata28, which creates efficient designs for DCEs using the
modified Fedorov algorithm29. The choice set was reduced
to 16 scenarios, which were split into two blocks of eight,
and half the respondents in each group were assigned to
each block. Overall, six versions of the DCE questionnaire
were used: two for patients, two for health professionals
and two for the general public.
The questionnaire also included a question asking
respondents to rank the six attributes according to their
overall importance, from 1 (most important) to 6 (least
important). Information on demographic, socioeconomic
and cancer-related experience was also collected (Appendix
S2, supporting information).
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Specialist MDT
Risk of death
Risk of complications
Specialist surgeon
No. of operations
Travel time
0 20 40
% of respondents
a  Patients (119 respondents)
c  General public (113 respondents)
b  Health professionals (96 respondents)
60 80 100
Risk of death
Risk of complications
Specialist MDT
No. of operations
Specialist surgeon
Travel time
0 20 40
% of respondents
60 80 100
Risk of death
Specialist surgeon
Risk of complications
No. of operations
Specialist MDT
Travel time
0 20 40
% of respondents
60 80 100
Most important
2
3
4
5
Least important
Fig. 2 Ranking of attributes by group: a patients, b health professionals and c general public. MDT, multidisciplinary team
© 2018 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS
on behalf of BJS Society Ltd.
L. Vallejo-Torres, M. Melnychuk, C. Vindrola-Padros, M. Aitchison, C. S. Clarke, N. J. Fulop et al.
0·8
P
ro
ba
bi
lit
y
1·0
0·6
0·4
0·2
0
W
or
st-
ca
se
 sc
en
ar
io*
Su
rg
eo
n 
24
/7
†
Sp
ec
ial
ist
 M
DT
‡
Lo
we
r c
om
pli
ca
tio
n 
ris
k§
Lo
we
r m
or
ta
lity
 ri
sk
¶
Be
st-
ca
se
 sc
en
ar
io#
Centralized service
Non-centralized service
Fig. 3 Predicted probabilities of choosing centralized cancer surgery services. Non-centralized service (comparator): 30 min travel time,
ten operations per year, no access to specialist multidisciplinary team (MDT), specialist surgeon cover during normal hours only, 5 per
cent risk of complication and 1⋅5 per cent risk of death; *worst-case scenario: centralized service with 120 min travel time, 100
operations per year, no access to specialist MDT, specialist surgeon cover during normal hours only, 5 per cent risk of complication and
1⋅5 per cent risk of death; †surgeon 24/7: centralized service with 120 min travel time, 100 operations per year, no access to specialist
MDT, specialist surgeon cover 24 h a day/7 days a week, 5 per cent risk of complication and 1⋅5 per cent risk of death; ‡specialist MDT:
centralized service with 120 min travel time, 100 operations per year, access to specialist MDT, specialist surgeon cover during normal
hours only, 5 per cent risk of complication and 1⋅5 per cent risk of death; §lower complication risk: centralized service with 120 min
travel time, 100 operations per year, no access to specialist MDT, specialist surgeon cover during normal hours only, 1 per cent risk of
complication and 1⋅5 per cent risk of death; ¶lower mortality risk: centralized service with 120 min travel time, 100 operations per year,
no access to specialist MDT, specialist surgeon cover during normal hours only, 5 per cent risk of complication and 0⋅5 per cent risk of
death; #best-case scenario: centralized service with 120 min travel time, 100 operations per year, access to specialist MDT, specialist
surgeon cover 24 h a day/7 days a week, 1 per cent risk of complication and 0⋅5 per cent risk of death.
The questionnaire was checked for the use of plain
English by the Plain English Campaign and piloted by
ten PPI representatives in London Cancer and Greater
Manchester Cancer. This resulted in minor improvements
being made to the wording of the questionnaire.
Data analysis
Descriptive statistics for the characteristics of partici-
pants who completed the questionnaire were computed.
Responses to the ranking questions are presented graph-
ically. Inter-rater agreement was measured using κ
statistics30.
The DCE data were analysed using a conditional logit
regression model in which the outcome was centre prefer-
ence (A or B) and the variables in the equation were the
individual attributes. A constant term was not included.
The model was run on the whole sample, as well as with
participants stratified by the three groups. Differences in
preferences between the groups were tested by comparing
the coefficients for each group using χ2 tests.
The travel time attribute was initially included using a
categorical specification with four categories (up to 30 min,
30–60 min, 60–90 min, 90–120 min). This specification
yielded a non-significant effect for each individual category,
but the joint effect across all categories was found to be sig-
nificant (Appendix S3, supporting information). This vari-
able was therefore also included as a continuous variable,
taking the higher-end value of each interval (30, 60, 90 and
120 min). The same results were obtained when alterna-
tive values were used (mid- or lower-end value), provided
the interval between values was preserved.
This specification of the travel time attribute also allowed
marginal rates of substitution (MRS) with respect to this
variable to be computed. The MRS allows direct assess-
ment of how much of one attribute participants are willing
to trade for one unit of another attribute, and therefore
enables a comparison of different attributes on a common
scale. Following the transformation of the travel time
attribute into a continuous measure, MRS values were
calculated using the travel time to hospital attribute as
the denominator so that participants’ preferences and the
trade-offs could be compared on a common value scale in
terms of willingness to travel.
In addition, regression analysis results were used to
calculate the predicted probabilities of choosing cancer
surgical services with attribute levels corresponding to the
goals of centralization, compared with a non-centralized
service. Specifically, the probability that a respondent
would choose a hypothetical non-centralized service was
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Table 3 Conditional logit regression analysis by group
Coefficient
Patients (n = 199)
Health professionals
(n = 109)
General public
(n = 125) P†
No. of observations 3124 1708 2002
Travel time to hospital for surgery (min) –0⋅003 (–0⋅005, –0⋅000) –0⋅003 (–0⋅006, 0⋅001)* 0⋅0003 (–0⋅003, 0⋅003)* 0⋅281
Risk of serious complications from surgery (%) –0⋅113 (–0⋅136, –0⋅090) –0⋅129 (–0⋅159, –0⋅100) –0⋅172 (–0⋅210, –0⋅134) 0⋅037
Risk of death within 30 days of surgery (%) –0⋅498 (–0⋅602, –0⋅395) –0⋅511 (–0⋅654, –0⋅369) –0⋅668 (–0⋅806, –0⋅530) 0⋅131
No. of operations carried out each year by centre for
each type of cancer
0⋅009 (0⋅007, 0⋅011) 0⋅009 (0⋅006, 0⋅012) 0⋅008 (0⋅006, 0⋅011) 0⋅923
Access to MDT to decide treatment
Local MDT – – –
Specialist MDT 0⋅377 (0⋅243, 0⋅511) 0⋅371 (0⋅222, 0⋅520) 0⋅535 (0⋅324, 0⋅746) 0⋅401
Availability of specialist surgeon cover after operation
During normal working hours – – –
24/7 0⋅346 (0⋅213, 0⋅478) 0⋅232 (0⋅073, 0⋅392) 0⋅354 (0⋅165, 0⋅542) 0⋅498
Values in parentheses are 95 per cent confidence intervals. MDT, multidisciplinary team; 24/7, 24 h a day, 7 days a week. *Coefficient not significantly
different from 0; all other coefficients significant at P < 0⋅050. †χ2 test.
compared against various different centralized service
scenarios. The hypothetical non-centralized service was
defined as: 30 min travel time, ten operations carried out
per year at the centre (for both attributes these were the
lowest levels included in the study), no access to a specialist
MDT, specialist surgeon cover during normal hours only,
a 5 per cent risk of complication and a 1⋅5 per cent risk of
death. In each ‘centralized’ scenario, the travel time was
fixed at 120 min, the number of operations at the centre
was increased to 100 per year (the highest level included
in the study), and the following potential characteristics
of a centralized service were added individually and then
jointly: access to a specialist MDT, access to specialist
surgeon cover 24 h a day, 7 days a week (24/7), risk of
complications reduced to 1 per cent, and risk of death
reduced to 0⋅5 per cent.
All analyses were undertaken using the software pack-
age Stata® version 12.0 (StataCorp, College Station,
Texas, USA).
Results
In total, 444 responses were received from July to Novem-
ber 2016, 206 from patients, 111 from health professionals
and 127 from members of the public. DCE questions were
completed in full by 199 patients, 109 health profession-
als and 125 members of the public. The response rate was
52⋅8 per cent for the patient sample; it was not possible to
estimate a response rate for the other groups as the survey
was sent via multiple overlapping distribution routes using
convenience sampling and snowball sampling techniques.
The analysis was a complete-case analysis using only these
respondents’ answers.
Of 199 patients, 41 were women (20⋅6 per cent), com-
pared with 45 (41⋅3 per cent) of the sample of health
professionals and 85 (68⋅0 per cent) of the general pub-
lic sample (Table 2). Mean ages were 69, 48 and 46 years
respectively. Among patients, the most common type of
cancer in the sample was prostate cancer (which explained
the imbalance of sexes in the patient sample), followed by
bladder cancer; most patients were diagnosed during the
year before the survey and had already undergone surgery.
Forty-three patients (21⋅6 per cent) had no formal qualifi-
cations and 44 (22⋅1 per cent) had a degree; 135 patients
(67⋅8 per cent) were retired at the time of the survey. In the
health professionals’ sample, 61 (56⋅0 per cent) were sur-
geons and 22 (20⋅2 per cent) were nurses. In the general
public sample, most respondents had a degree and were
working full time. In all three groups there was a mix of
respondents from London, Greater Manchester and the
rest of England.
Simple attribute ranking
The responses to the ranking question posed before the
DCE questions were examined. Only 328 respondents
(119 patients, 96 health professionals and 113 members
of the public) provided full responses to this question.
Fig. 2 shows the responses for each of the three groups
separately. Attributes were ranked by likelihood of being
selected as the most important factor. The κ statistic over-
all was 0⋅1166; it was 0⋅0765, 0⋅1268 and 0⋅1501 for health
professionals, patients and the general public respectively,
representing slight agreement among rankers in each
case31.
Using this method of ranking, risk of death and risk
of complications were ranked highly in each sample, and
travel time was consistently considered to be the least
important factor by each group. Some differences between
groups were noted: patients appeared to consider the
availability of a specialist MDT team highly important,
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Table 4 Conditional logit analysis regression results for total sample
Coefficient Willingness to travel to hospital (min)*
Travel time to hospital for surgery (min) –0⋅002 (–0⋅003, –0⋅0002) –
Risk of serious complications from surgery (%) –0⋅132 (–0⋅149, –0⋅116) 75
Risk of death within 30 days of surgery (%) –0⋅544 (–0⋅615, –0⋅473) 307
No. of operations carried out each year by centre for each type of cancer 0⋅009 (0⋅007, 0⋅010) –5
Access to MDT to decide treatment
Local MDT – –
Specialist MDT 0⋅414 (0⋅322, 0⋅507) –234
Availability of specialist surgeon cover after operation
During normal working hours –
24/7 0⋅308 (0⋅219, 0⋅397) –174
Values in parentheses are 95 per cent confidence intervals. The data are based on 6834 observations among 433 respondents. *Marginal rates of
substitution (MRS) computed by dividing each coefficient by the coefficient for travel time to hospital. The coefficients presented are rounded and
therefore MRS values are not identical to the ratio of the coefficients shown in the table. MDT, multidisciplinary team; 24/7, 24 h a day, 7 days a week.
whereas health professionals considered the availability of a
specialist surgeon 24/7 more important (note that 56⋅0 per
cent of the healthcare professionals’ sample were surgeons).
Discrete-choice experiment analysis
There were no statistically significant differences in the
effects of the attributes between groups, with the exception
of the risk of complications, which had a slightly larger
impact in the public sample compared with the patient
sample (Table 3). Therefore, the study focused on themodel
conducted on the whole sample (Table 4).
As expected, individuals preferred to have surgery in a
centre with better attribute levels: requiring shorter travel
time, where the risk of complications and the risk of death
were lower, the number of operations carried out each year
was larger, and where there was access to a specialist MDT
and to specialist surgeon cover 24/7. The MRS showed
the relative importance of each attribute by enabling the
comparison of different attributes on a common scale.
Participants were willing to travel 75 min longer in order
to reduce the risk of complications by 1 per cent, and over
5 h longer to reduce their risk of death after surgery by 1
per cent. Their willingness to travel increased by 5 min for
every additional procedure carried out by the centre each
year, and by approximately 4 h to have access to a specialist
MDT team and 3 h for 24/7 access to specialist surgeon
cover. These MRS values reflected the ranking shown
in Fig. 2, in particular the relatively lower importance of
travel time.
The probability that respondents would choose a centre
with attribute levels corresponding to a centralized service
compared with a non-centralized service is shown in Fig.
3. Compared with a centre requiring 30 min travel time
and which carries out ten operations a year (a generic
non-centralized service), respondents were less likely to
choose a centre that carries out 100 operations a year but
for which the travel time increases to 120 min, holding the
rest of the attributes constant (a centralized service where
the only difference compared with a non-centralized ser-
vice is in terms of travel burden and number of operations;
worst-case scenario in Fig. 3). However, the probability
that respondents would choose the centralized service
increased if the centre achieved the goals of centralization
with respect to each of the other attributes: the probability
was 72 per cent if the centre provides access to specialist
surgeon cover 24/7, 74 per cent if there is access to a
specialist MDT, 76 per cent if the risk of complications
is reduced from 5 to 1 per cent, and 76 per cent if the
risk of death is reduced from 1⋅5 to 0⋅5 per cent. If the
centralized service achieved all of these changes in the
attributes, at the expense of increasing travel time from 30
to 120 min (best-case scenario in Fig. 3), the probability
that respondents would prefer to have surgery in the
centralized centre reached 92 per cent.
Further subgroup analyses were undertaken, stratifying
the whole sample by age (below 60 years versus 60 years
or older), sex and place of residence (London, Greater
Manchester and the rest of England). No consistent differ-
ences were observed. These variables were also included as
control variables in the main model, but the control vari-
ables were found to be non-significant and the sign and
significance of the attributes remained unchanged.
Discussion
Patients, health professionals and the public all preferred
shorter travel times, lower risks of death and complications,
and access to centres carrying out more operations, with
more specialized teams and surgeons. Preferences were
particularly influenced by the risk of complications, the risk
of death and access to a specialist MDT. Travel time was
the least important factor. Preferences were found to be
consistent with the goals of centralization.
The probability that participants would choose to have
surgery in a centre successfully meeting the aims of
© 2018 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS
on behalf of BJS Society Ltd.
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centralization was high. However, the impact on mortality
and complications assumed in this best-case scenario was
hypothetical, and might not be achieved. It was also found
that, if centralization increased travel time for surgery at
a hospital carrying out a larger number of operations in a
year, but did not improve access to a specialist MDT or
specialist surgeon cover 24/7, and did not reduce the risk
of death and/or complications, then participants would
prefer to have surgery in a non-centralized centre. There-
fore, achieving outcomes associated with higher volumes
is crucial.
Several limitations are acknowledged. DCEs elicit hypo-
thetical choices, and therefore might lack external validity
if individuals do not make the same choices in real-life
situations. Some aspects of the choices might be difficult
for respondents to understand, such as probabilities and
clinical concepts. The representativeness of the samples
used might be limited by the recruitment strategies, yield-
ing potential sampling bias. The findings are unlikely to
be generalizable to less urban areas where travel distances
may be longer, or to countries where travel distances are
considerably larger. There might be other factors affected
by centralization that are important but were not included
in the present analysis; they could not be included because
the number of attributes/levels was predefined. Another
limitation is that preferences for specific specialist cancer
surgery services were analysed, and these preferences
might be different for other types of cancer. For example,
for some cancers the risk of death and complications is
low, and in this case the importance of other attributes,
including travel time, may be more pronounced. Travel
costs, which might have a different effect on individual’s
preferences compared with travel time, were not assessed.
Furthermore, the importance of travel time for surgery
might be more important for family members than patients
because they might travel more frequently. Analyses based
on respondents who did, or did not have friends and rel-
atives diagnosed with cancer showed that travel time only
affected preferences among those with a family member
(or close friend) with cancer.
The findings of this study highlight that people are
willing to trade travel time for better outcomes and quality
of care, in line with policy documents emphasizing the
need to centralize specialist care1. It is important to note
that this relates to surgery for the specified types of cancer
and does not necessarily apply to other treatments (such as
chemotherapy), which may be provided at local hospitals,
or to other types of cancer. Planners who are redesigning
services might consider, measure and communicate the
impact of reorganization on the factors identified in this
study.
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